Trial intelligence / Profile preview

Mesenchymal Stem Cells for Cerebellar Ataxia

NCT01649687Phase 2Completed

Sponsor
National Yang Ming Chiao Tung University
Start
May 2012
Primary completion
Jan 2014
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of CSCC_ASC in spinocerebellar ataxia type 3 (SCA3), multiple system atrophy (MSA), sponsored by National Yang Ming Chiao Tung University. Started May 2012; status: completed.

02

Drugs

CSCC_ASC
03

Conditions

spinocerebellar ataxia type 3 (SCA3)multiple system atrophy (MSA)

Beyond the preview

Go deeper on NCT01649687.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01649687.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call